UNSPSC 41131701: Adenosine triphosphate release assay

In this classification an adenosine triphosphate release assay is a device that measures the release of adenosine triphosphate (ATP) from platelets following aggregation. This measurement is made on platelet-rich plasma using a photometer and a luminescent firefly extract. Simultaneous measurements of platelet aggregation and ATP release are used to evaluate platelet function disorders US FDA regulates Adenosine triphosphate release assay under 21 CFR 864.7040 and under FDA product code KHF.

UNSPSC 41131701 Adenosine triphosphate release assay (Commodity) covers laboratory drug testing and substance screening services procured by state and local health, corrections, and law enforcement agencies. The code captures immunoassay screening with confirmatory analysis (LC/MS/MS, GC/MS), urinalysis testing, and multi-panel drug screening (five-panel, six-panel) for offender monitoring, employment pre-screening, fitness-for-duty evaluation, and clinical psychiatric monitoring. State and local buyers under this code include county corrections and community supervision departments, county health departments, county human resources divisions, city college systems, and state law enforcement agencies. Testing is delivered through contracted laboratory networks with specimen collection either on-site at county facilities or through distributed provider sites, with results reported electronically and turnaround typically 48–72 hours for standard screening and confirmation.

Recent activity spans Texas, Florida, Oregon, and Nevada. Collin County Community Supervision and Corrections Department issued RFP 2026-327 (due July 23, 2026) for offender specimen collection and drug testing at two collection sites in Plano and McKinney, with approximately 25,031 annual tests across five-panel and six-panel screens and ancillary testing; the estimated contract value is $600,000 over two years with optional three one-year renewals, awarded on best-value basis with 30-point cost weighting. Benton County, Oregon issued RFP SC0200300017156 (due July 7, 2026) for urinalysis testing supporting its Family Treatment Court Program, requiring CLIA-certified laboratory with twice-weekly testing and specimen collection supplies provided by the contractor. Clay County Board of County Commissioners in Florida issued IFB 2526054 for physicals and drug testing for non-union and public safety personnel, with a three-year contract term and optional two one-year renewals. City Colleges of Chicago issued RFP MWJ2603 (due March 30, 2026) for employment screening services including non-NIDA five and nine-panel drug screening and Medical Review Officer services for approximately 1,500–1,600 annual candidate screens, with 25% MBE and 7% WBE participation goals. The code also reflects forensic laboratory procurement: Pinellas County, Florida procured certified drug reference standards (ITQ 26-0305-ITQ) through the Paul Coverdell Forensic Sciences Improvement Act Program, with $49,034.00 of $72,126.85 in federal funds designated for equipment and supplies including drug standards.